Hawkins (NASDAQ:HWKN – Get Free Report) will likely be posting its Q4 2026 results after the market closes on Wednesday, May 13th. Analysts expect Hawkins to post earnings of $0.77 per share and revenue of $255.2840 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Wednesday, May 13, 2026 at 4:10 PM ET.
Hawkins Price Performance
HWKN opened at $167.00 on Wednesday. The stock has a market cap of $3.49 billion, a price-to-earnings ratio of 42.28, a PEG ratio of 3.16 and a beta of 0.81. Hawkins has a 1 year low of $115.35 and a 1 year high of $186.15. The company has a current ratio of 2.35, a quick ratio of 1.46 and a debt-to-equity ratio of 0.49. The stock has a fifty day moving average price of $151.20 and a 200 day moving average price of $146.01.
Analyst Upgrades and Downgrades
HWKN has been the topic of a number of recent research reports. Weiss Ratings restated a “hold (c+)” rating on shares of Hawkins in a report on Friday, April 10th. BWS Financial reiterated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a report on Monday, March 23rd. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Hawkins currently has an average rating of “Hold” and a consensus target price of $200.00.
Hedge Funds Weigh In On Hawkins
A number of institutional investors have recently made changes to their positions in the business. Wasatch Advisors LP lifted its position in shares of Hawkins by 31.4% during the 4th quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock worth $78,477,000 after purchasing an additional 131,850 shares during the last quarter. Invesco Ltd. grew its holdings in Hawkins by 44.4% in the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock valued at $74,512,000 after buying an additional 125,444 shares during the last quarter. State Street Corp increased its position in Hawkins by 11.6% in the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock worth $151,642,000 after buying an additional 111,318 shares during the period. UBS Group AG lifted its holdings in shares of Hawkins by 103.1% during the third quarter. UBS Group AG now owns 49,050 shares of the specialty chemicals company’s stock worth $8,962,000 after buying an additional 24,904 shares during the last quarter. Finally, Raymond James Financial Inc. boosted its position in shares of Hawkins by 32.9% in the third quarter. Raymond James Financial Inc. now owns 96,329 shares of the specialty chemicals company’s stock valued at $17,601,000 after acquiring an additional 23,841 shares during the period. 69.71% of the stock is currently owned by institutional investors.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Featured Stories
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
